BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26176038)

  • 1. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
    Jiang S; Pei L; Yang ZL; Liu G
    Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
    Yuan LW; Liu DC; Yang ZL
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.
    Yang L; Lan S; Liu J; Yang Z
    Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
    Yang L; Guo T; Jiang S; Yang Z
    Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
    Liu DC; Yang ZL
    Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma.
    Yang LP; Jiang S; Liu JQ; Miao XY; Yang ZL
    Hepatogastroenterology; 2012 Oct; 59(119):2089-94. PubMed ID: 22497866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
    Liu DC; Yang ZL; Jiang S
    Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
    Xiong L; Yang Z; Yang L; Liu J; Miao X
    J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
    Liu DC; Yang ZL
    Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 expression is correlated with poor prognosis in colorectal cancer.
    Kashihara H; Shimada M; Kurita N; Iwata T; Sato H; Kozo Yoshikawa ; Higashijima J; Chikakiyo M; Nishi M; Matsumoto N
    Hepatogastroenterology; 2014 Sep; 61(134):1563-7. PubMed ID: 25436343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
    Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
    Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
    Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
    J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
    Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
    Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
    Shu GS; Lv F; Yang ZL; Miao XY
    Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.
    Prince S; Zeidman A; Dekel Y; Ram E; Koren R
    Am J Clin Pathol; 2008 Mar; 129(3):424-9. PubMed ID: 18285265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
    Xiong L; Deng X; Wen Y; Yang Z; Miao X
    World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
    Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
    Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.